Overview

Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye Disease

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and tolerability of P-321 Ophthalmic Solution in subjects with mild to moderate dry eye disease.
Phase:
Phase 1
Details
Lead Sponsor:
Parion Sciences
Treatments:
Ophthalmic Solutions
Pharmaceutical Solutions